Under the guidance of leading Regenerative Medicine expert and Chief Scientific Officer Dr. Corey Orava, DVM, Enso Discoveries has developed and university-validated an effective, multi-species, low-cost Platelet Rich Fibrin (PRF) kit for use in veterinary medicine.

MANHATTAN, KAN. (PRWEB) MAY 16, 2019 — Enso Discoveries Chief Scientific Officer, Dr. Corey Orava, DVM, has developed and brought to market a patent pending, affordable, effective, easy-to-use, university-validated Platelet Rich Fibrin (PRF) kit for veterinarians to be used with both equine and companion animals. This latest achievement is a testament to the dedication of the Enso Discoveries team to be the foremost leader in providing affordable, accessible, and scientifically-advanced veterinary regenerative medicine products. Enso Discoveries has advanced this goal by offering in-house products with no capital start-up fees or long-term financial risk for veterinarians and clinics.

“There has long been a need in the regenerative medicine space for improved products that are cost-effective, and have a focus on what is best for the animal and the practice,” said Patrick Farley, CEO of Enso Discoveries. “Thanks to such new developments as our PRF kit, which uses our proprietary Expressate system, we have been able to help veterinarians around the country save multiple animals that were scheduled for amputation or euthanasia. We are very proud to be saving animals here and giving their owners new hope!”

The first of its kind in veterinary medicine, the PRF kit by Enso Discoveries works quickly and efficiently: the entire process can be done in under 30 minutes (with most of the work done by support staff or veterinary technicians) and by using the PRF membrane as a second-generation autologous blood product, removing the risk of rejection